Literature DB >> 32710450

Late-onset epilepsy and 25-year cognitive change: The Atherosclerosis Risk in Communities (ARIC) study.

Emily L Johnson1, Gregory L Krauss1, Keenan A Walker1, Jason Brandt1,2, Anna Kucharska-Newton3, Thomas H Mosley4, Sevil Yasar5, Rebecca F Gottesman1,6.   

Abstract

OBJECTIVE: To define the association between late-onset epilepsy (LOE) and 25-year change in cognitive performance.
METHODS: The Atherosclerosis Risk in Communities (ARIC) study is a multicenter longitudinal cohort study with participants from four U.S. communities. From linked Medicare claims, we identified cases of LOE, defined as ≥2 seizure-related diagnostic codes starting at age ≥67. The ARIC cohort underwent evaluation with in-person visits at intervals of 3-15 years. Cognition was evaluated 4 times over >25 years (including before the onset of seizures) using the Delayed Word Recall Test (DWRT), Digit Symbol Substitution Test (DSST), and Word Fluency Test (WFT); a global z-score was also calculated. We compared the longitudinal cognitive changes of participants with and without LOE, adjusting for demographics and LOE risk factors.
RESULTS: From 8033 ARIC participants with midlife cognitive testing and Medicare claims data available (4523 [56%] female, 1392 [17%] Black), we identified 585 cases of LOE. The rate of cognitive decline was increased on all measures in the participants who developed LOE compared to those without LOE. On the measure of global cognition, participants with LOE declined by -0.43 z-score points more over 25 years than did participants without epilepsy (95% confidence interval [CI] -0.59 to -0.27). Prior to the onset of seizures, cognitive decline was more rapid on the DWRT, DSST, and global z-scores in those who would later develop LOE than it was in non-LOE participants. Results were similar after excluding data from participants with dementia. SIGNIFICANCE: Global cognition, verbal memory, executive function, and word fluency declined faster over time in persons developing LOE than without LOE. Declines in cognition preceding LOE suggest these are linked; it will be important to investigate causes for midlife cognitive declines associated with LOE.
© 2020 International League Against Epilepsy.

Entities:  

Keywords:  cognition; dementia; epilepsy; late-onset; longitudinal

Mesh:

Year:  2020        PMID: 32710450      PMCID: PMC7718433          DOI: 10.1111/epi.16616

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  48 in total

Review 1.  Epileptic activity in Alzheimer's disease: causes and clinical relevance.

Authors:  Keith A Vossel; Maria C Tartaglia; Haakon B Nygaard; Adam Z Zeman; Bruce L Miller
Journal:  Lancet Neurol       Date:  2017-04       Impact factor: 44.182

2.  Prior hospitalization for stroke, diabetes, myocardial infarction, and subsequent risk of unprovoked seizures.

Authors:  Cecilia Adelöw; Tomas Andersson; Anders Ahlbom; Torbjörn Tomson
Journal:  Epilepsia       Date:  2010-11-03       Impact factor: 5.864

3.  New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine.

Authors:  A J Rowan; R E Ramsay; J F Collins; F Pryor; K D Boardman; B M Uthman; M Spitz; T Frederick; A Towne; G S Carter; W Marks; J Felicetta; M L Tomyanovich
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

4.  Cerebral small-vessel disease and decline in information processing speed, executive function and memory.

Authors:  Niels D Prins; Ewoud J van Dijk; Tom den Heijer; Sarah E Vermeer; Jellemer Jolles; Peter J Koudstaal; Albert Hofman; Monique M B Breteler
Journal:  Brain       Date:  2005-06-09       Impact factor: 13.501

5.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.

Authors:  Tiia Ngandu; Jenni Lehtisalo; Alina Solomon; Esko Levälahti; Satu Ahtiluoto; Riitta Antikainen; Lars Bäckman; Tuomo Hänninen; Antti Jula; Tiina Laatikainen; Jaana Lindström; Francesca Mangialasche; Teemu Paajanen; Satu Pajala; Markku Peltonen; Rainer Rauramaa; Anna Stigsdotter-Neely; Timo Strandberg; Jaakko Tuomilehto; Hilkka Soininen; Miia Kivipelto
Journal:  Lancet       Date:  2015-03-12       Impact factor: 79.321

6.  Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study.

Authors:  Emily L Johnson; Gregory L Krauss; Alexandra K Lee; Andrea L C Schneider; Jennifer L Dearborn; Anna M Kucharska-Newton; Juebin Huang; Alvaro Alonso; Rebecca F Gottesman
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

7.  Epileptic seizure semiology in different age groups.

Authors:  Guadalupe Fernandez-Baca Vaca; Carlos L Mayor; Naira García Losarcos; Jun T Park; Hans O Lüders
Journal:  Epileptic Disord       Date:  2018-06-01       Impact factor: 1.819

8.  The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE.

Authors:  Rebecca F Gottesman; Andrea L C Schneider; Yun Zhou; Xueqi Chen; Edward Green; Naresh Gupta; David S Knopman; Akiva Mintz; Arman Rahmim; A Richey Sharrett; Lynne E Wagenknecht; Dean F Wong; Thomas H Mosley
Journal:  Neurology       Date:  2016-07-01       Impact factor: 9.910

Review 9.  Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease.

Authors:  D Allan Butterfield; Barry Halliwell
Journal:  Nat Rev Neurosci       Date:  2019-03       Impact factor: 38.755

10.  Cognitive decline in severe intractable epilepsy.

Authors:  Pamela J Thompson; John S Duncan
Journal:  Epilepsia       Date:  2005-11       Impact factor: 5.864

View more
  2 in total

Review 1.  Late-onset epilepsy and the risk of dementia: a systematic review and meta-analysis.

Authors:  Lei Huang; Chi Fu; Jie Li; Shijun Peng
Journal:  Aging Clin Exp Res       Date:  2022-04-15       Impact factor: 4.481

Review 2.  The clinical correlation between Alzheimer's disease and epilepsy.

Authors:  Dandan Zhang; Siyuan Chen; Shoucheng Xu; Jing Wu; Yuansu Zhuang; Wei Cao; Xiaopeng Chen; Xuezhong Li
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.